Replies to post #141196 on Anavex Life Sciences Corp (AVXL)

[frrol]

One was, and is already approved for AD. In fact people have been taking it for years. And its S1 agonism is not having much effect.

S1 potency might not be an advantage factor. We don't know if something else would be, what it would be, (duration, domain, conformity?), and if 2-73 posseses that relative advantage. So we wait.

[sliceanddice59]

And they likely don't have muscarinic effects.